Group items tagged

The Clinical Laboratory Improvement Amendments of 1988 All clinical laboratory testing done on humans in the US, save those done for basic research and clinical trials, have to comply with the provisions of the Clinical Laboratory Improvement Amendments (CLIA). Clinical Laboratory Improvement Amendments, a set of federal amendments carried out in 1988 set out federal standards for carrying out clinical laboratory testing. A clinical laboratory is, according to the CLIA, a facility in which laboratory testing is done on samples procured from humans. This testing is done with the aim of obtaining information with the intention of evaluating health, using which clinicians diagnose, prevent, or treat disease. Having defined a clinical laboratory thus, the Clinical Laboratory Improvement Amendments set out the regulatory guidelines on which clinical trials are to be administered. The fundamental aim of the Clinical Laboratory Improvement Amendments is to ensure accuracy, efficacy, safety, reliability and efficiency of clinical trials. The Clinical Laboratory Improvement Amendments seek to do this by setting aside grades for a range of criteria that relate to these aspects of the clinical trial. These grades are given from a score of 1, meaning the lowest, to 3, the highest, to assess as many as seven criteria of a particular clinical trial. These seven criteria are: Knowledge Materials used in proficiency, quality control, and calibration of materials Features of operational steps Experience and training Troubleshooting of test system troubleshooting and maintenance of equipment Preparation of reagents and other materials Interpreting and judging the results of the tests Points to be borne in mind for enforcing provisions of the Clinical Laboratory Improvement Amendments Provisions set out in the Clinical Laboratory Improvement Amendments are to be enforced through a set of parameters. These include: Procedure manual A basic part of the Clinical Lab

Overview: This webinar will explain the details of how to report and what to report on the OSHA Injury and Illness report. It will include an explanation of how to determine if an injury is work related, if an injury is new or ongoing, and what the differences are between first aid and medical treatment. A specific list of what constitutes injuries, illnesses and first aid treatment will be provided, along with practical examples of how to determine if an injury should be reported. In addition, examples of the forms used to report injuries, as well as annual summaries will be presented. Why should you attend: OSHA Injury and Illness Record keeping provides a window for regulators to see into your business to determine if the work environment is safe or if there are problems. Correct reporting of injury and illness data and a clear understanding of what to report and how to report it is a key necessity to avoid potential inspections and fines. Areas Covered in the Session: Injury and Illness reporting Determination of workplace relatedness Differences between first aid and medical treatment Determination of case as new or ongoing How to count total lost days Advantages that a company can provide to reduce risks of inspections and fines Who Will Benefit: Safety Personnel HR Personnel Managers Executives Speaker Profile Kenneth S. Weinberg is an independent consultant in environmental health and safety. Dr. Weinberg has consulted for several companies in the areas of OSHA Injury and Illness reporting, as well as auditing for OSHA inspections. He has worked as the Director of Safety at Mass. General Hospital in Boston for almost twelve years, and has written several books on the topics of health care safety, OSHA, and Indoor Air Quality. He has also written several articles for prominent national safety publications, and serves on the editorial advisory boards for safety publications. He Also has been Administrator of the Health Care Divisio0n of the American Socie